GO:1902177 positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway: Apoptosis Amplifier, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902177 describes any process that activates or increases the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway.
• The term sits at the intersection of redox biology and mitochondrial apoptosis, where reactive oxygen species (ROS) trigger BAX/BAK-dependent mitochondrial outer membrane permeabilization.
• Positive regulators include pro-apoptotic BCL-2 family members, p53-family transcription factors, JNK/p38 MAPK modules, and mitochondrial fission machinery.
• Dysregulation of this process contributes to neurodegeneration, ischemia-reperfusion injury, cardiomyopathy, and resistance to cancer therapy.
• Experimental dissection relies on H2O2 or rotenone challenge combined with caspase-3/7 activity, cytochrome c release, JC-1 mitochondrial potential, and TUNEL assays.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of candidate positive regulators in isogenic cell backgrounds.
Description
GO:1902177, positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway, is a Gene Ontology biological process term that captures any molecular event that amplifies or accelerates the mitochondrial (intrinsic) apoptotic cascade when cells experience oxidative stress. Oxidative stress arises when ROS production exceeds antioxidant capacity, and the intrinsic pathway responds by permeabilizing mitochondria and releasing cytochrome c, which activates caspase-9 and downstream executioner caspases. Because this process is a central decision point between cell survival and death, it is heavily studied in neurodegeneration, cardiovascular disease, and oncology. Researchers use GO:1902177 to annotate genes whose products enhance, rather than merely permit, oxidative stress-induced apoptosis, making it a precise functional label for gain-of-function or sensitizing factors. The term is therefore essential for interpreting transcriptomic and proteomic datasets where redox-sensitive death signaling is a key phenotype.
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway At A Glance
| GO ID | GO:1902177 |
|---|---|
| GO term | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
| Ontology | biological_process |
| Synonym | activation of intrinsic apoptotic signaling pathway in response to oxidative stress; positive regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; up regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; up-regulation of intrinsic apoptotic signaling pathway in response to oxidative stress; upregulation of intrinsic apoptotic signaling pathway in response to oxidative stress |
| Major function | Amplification of mitochondrial apoptosis signaling under oxidative stress conditions |
| Definition source | QuickGO definition: Any process that activates or increases the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway |
| Related process | Intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0097193) |
| Cellular context | Mitochondria, cytosol, and nucleus |
| Disease relevance | Neurodegeneration, ischemia-reperfusion injury, cardiomyopathy, cancer therapy resistance |
What Is GO:1902177?
In plain terms, GO:1902177 covers any process that turns up the volume on the mitochondrial apoptosis pathway when a cell is under oxidative stress. The QuickGO definition states: Any process that activates or increases the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway. This means the annotated gene product must act as a positive regulator, not merely be required for the pathway to occur. The intrinsic pathway is mitochondria-centered and distinct from death-receptor (extrinsic) apoptosis, so positive regulators include factors that promote mitochondrial outer membrane permeabilization, cytochrome c release, apoptosome formation, or caspase-9 activation specifically in response to ROS.
Why Is positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway Important in Cell Biology?
GO:1902177 matters because oxidative stress-induced intrinsic apoptosis is a final common pathway in many acute and chronic diseases, and positive regulators of this pathway are attractive targets for both disease prevention and cancer therapy. In neurodegeneration and ischemia, excessive positive regulation accelerates cell loss, whereas in cancer, loss of positive regulators contributes to apoptosis resistance and treatment failure. Understanding which genes positively regulate this process, and how, allows researchers to design mechanism-based interventions and to interpret omics data with functional precision.
• Defines a precise functional class of genes that amplify, rather than merely permit, oxidative stress-induced mitochondrial apoptosis.
• Central to neuronal death in temporal lobe epilepsy and other neurodegenerative conditions where oxidative stress is a driver.
• Relevant to diabetic retinopathy, where pericyte loss involves oxidative stress and mitochondrial dysfunction.
• Provides a mechanistic framework for cardioprotection, as shown by compounds that protect H9c2 cardiomyoblasts from H2O2-induced apoptosis.
• Supports cancer research by identifying sensitizers that restore apoptosis in therapy-resistant tumors.
• Guides interpretation of proteomic and transcriptomic datasets in redox biology and cell death.
• Enables causal testing through CRISPR knockout, point mutation, knock-in, and overexpression models.
• Links mitochondrial dynamics, MAPK signaling, and p53-family transcription to a single annotated process.
• Facilitates cross-species comparison of apoptosis regulators in human, rodent, and stem cell models.
• Underpins development of biomarkers and therapeutic strategies targeting oxidative stress-induced cell death.
What Happens During positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway?
Oxidative stress sensing and ROS accumulation
In simple terms: The cell first detects an imbalance between reactive oxygen species and antioxidants.
Positive regulation begins when ROS such as superoxide and hydrogen peroxide accumulate beyond antioxidant capacity, modifying redox-sensitive cysteines on signaling proteins. In cardiomyoblast models, H2O2 challenge is used experimentally to trigger this initial stress, and protective compounds such as chlorogenic acid analogues can attenuate the downstream apoptotic response. In diabetic donor eyes, oxidative stress in retinal pericytes is associated with proteome changes that reflect stress responses and cell vulnerability. This sensing step is not itself apoptosis but sets the stage for positive regulators to act.
Activation of pro-apoptotic BCL-2 family effectors
In simple terms: Stress signals switch on proteins that punch holes in mitochondria.
Positive regulators include BAX, BAK, and BH3-only proteins such as BIM and PUMA, which are activated or upregulated under oxidative stress and promote mitochondrial outer membrane permeabilization. The balance between anti-apoptotic BCL-2/BCL-xL and these effectors determines whether the pathway proceeds, and positive regulation of GO:1902177 specifically refers to processes that tip this balance toward permeabilization. Experimental evidence in H9c2 cells shows that H2O2-induced apoptosis can be blocked by agents that preserve mitochondrial integrity, confirming that BCL-2 family effectors are actionable nodes in this process.
Mitochondrial outer membrane permeabilization and cytochrome c release
In simple terms: Once the mitochondrial barrier is breached, cytochrome c escapes into the cytosol.
Following BAX/BAK activation, mitochondrial outer membrane permeabilization releases cytochrome c and other intermembrane space proteins into the cytosol. This step is a point of no return and is positively regulated by factors that enhance pore formation or mitochondrial fission. In retinal pericyte proteomics from diabetic donors, mitochondrial and stress-response proteins are altered, consistent with mitochondrial dysfunction in oxidative stress-related cell loss. Assays measuring cytochrome c release and mitochondrial membrane potential are standard readouts for this stage.
Apoptosome assembly and caspase-9 activation
In simple terms: Cytochrome c builds a platform that activates the initiator caspase.
Cytosolic cytochrome c binds APAF-1 to form the apoptosome, which recruits and activates caspase-9. Positive regulation of GO:1902177 includes processes that increase apoptosome formation or caspase-9 activity in response to oxidative stress. Downstream executioner caspases-3 and -7 are then activated, leading to substrate cleavage and cell death. Caspase-3/7 activity assays are widely used to quantify this stage in cell models challenged with H2O2 or other ROS generators.
Execution phase and cellular dismantling
In simple terms: Executioner caspases dismantle the cell in an orderly way.
Activated caspase-3 and caspase-7 cleave structural and repair proteins, producing the morphological hallmarks of apoptosis including DNA fragmentation. Positive regulators that act at or upstream of this execution phase amplify the overall rate of cell death under oxidative stress. In stem cell and tissue contexts, exercise-related interventions have been associated with reduced inflammatory and senescence factors in bone marrow mesenchymal stem cells, highlighting that oxidative stress and apoptosis regulation are relevant to regenerative biology. TUNEL and Annexin V assays are commonly used to measure this final stage.
Key Genes Involved in GO:1902177 positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway
The following genes and proteins are experimentally or mechanistically linked to positive regulation of oxidative stress-induced intrinsic apoptotic signaling, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BAX | Pro-apoptotic effector that permeabilizes mitochondria | Central node for positive regulation; knockout confers resistance to H2O2-induced apoptosis |
| BAK | Pro-apoptotic effector cooperating with BAX | Required for mitochondrial outer membrane permeabilization in many cell types |
| BID | BH3-only protein linking stress signals to BAX/BAK | Amplifies intrinsic apoptosis under oxidative stress |
| BIM | BH3-only sensitizer activated by stress kinases | Positive regulator downstream of JNK/p38 in oxidative stress |
| PUMA | p53-inducible BH3-only protein | Links DNA damage and oxidative stress to mitochondrial apoptosis |
| TP53 | Transcription factor inducing PUMA, BAX, and other pro-apoptotic genes | Master positive regulator of oxidative stress-induced apoptosis |
| APAF-1 | Apoptosome scaffold that activates caspase-9 | Essential for cytochrome c-dependent caspase activation |
| CASP9 | Initiator caspase activated by apoptosome | Readout of intrinsic pathway engagement |
| CASP3 | Executioner caspase | Common endpoint assay for apoptosis quantification |
| CASP7 | Executioner caspase cooperating with caspase-3 | Contributes to apoptotic dismantling |
| BCL2 | Anti-apoptotic guardian of mitochondrial integrity | Its balance with BAX/BAK determines pathway outcome |
| BCL2L1 | Anti-apoptotic BCL-xL | Counteracts positive regulators; target for sensitization |
| MAPK8 | JNK kinase responsive to oxidative stress | Phosphorylates and activates BH3-only proteins |
| MAPK14 | p38 kinase responsive to oxidative stress | Contributes to pro-apoptotic signaling |
| CYCS | Cytochrome c released from mitochondria | Direct activator of apoptosome assembly |
| DIABLO | SMAC/DIABLO antagonist of IAPs | Enhances caspase activation after mitochondrial permeabilization |
| PRDX3 | Mitochondrial peroxidase modulating ROS | Alters threshold for oxidative stress-induced apoptosis |
How Is positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway Regulated?
Positive regulation of oxidative stress-induced intrinsic apoptotic signaling is controlled at multiple levels. Upstream, ROS modify redox-sensitive cysteines on kinases such as JNK and p38, which phosphorylate BH3-only proteins and promote their pro-apoptotic activity. Transcriptionally, p53-family factors induce PUMA, BAX, and other effectors, creating a feed-forward amplification loop. Anti-apoptotic BCL-2 family proteins set the threshold by sequestering BH3-only proteins, so their abundance and post-translational modifications determine whether positive regulation dominates. Mitochondrial dynamics also regulate the process, since fission favors permeabilization while fusion is protective. In tissue contexts, inflammatory and senescence-related factors can modulate oxidative stress responses, as observed in bone marrow mesenchymal stem cells after exercise interventions. Proteomic studies of diabetic retinal pericytes further indicate that chronic oxidative stress reshapes the mitochondrial and stress-response proteome, which can alter apoptotic thresholds.
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Cancer therapy resistance and neurodegeneration | Isogenic TP53 knockout and point-mutation cell lines challenged with H2O2 |
| BAX | Cardiomyopathy and ischemia-reperfusion injury | BAX knockout H9c2 or primary cardiomyocytes with H2O2 treatment |
| PRDX3 | Diabetic retinopathy and oxidative stress | Retinal pericyte-like cells with PRDX3 overexpression or knockout |
| MAPK8 | Temporal lobe epilepsy and neurodegeneration | Neuronal cell lines with JNK knockout and oxidative stress challenge |
| CASP3 | Apoptosis execution in multiple diseases | CASP3 knockout cells for apoptosis quantification assays |
Neurodegeneration and temporal lobe epilepsy
Oxidative stress-induced intrinsic apoptosis contributes to neuronal loss in chronic neurological disorders. Proteomic biomarker studies in temporal lobe epilepsy highlight oxidative stress and mitochondrial dysfunction as recurring themes, supporting a role for positive regulators of this pathway in seizure-related neurodegeneration. Targeting these positive regulators could reduce neuronal death, but must be balanced against physiological apoptosis.
Diabetic retinopathy and vascular cell loss
In diabetic donor eyes, retinal pericyte proteomes show alterations consistent with oxidative stress and cell vulnerability, and pericyte loss is a hallmark of diabetic retinopathy. Positive regulation of oxidative stress-induced intrinsic apoptosis is therefore mechanistically relevant to microvascular degeneration, and pericyte models can be used to test candidate regulators.
Cardiomyopathy and ischemia-reperfusion injury
H9c2 cardiomyoblast studies demonstrate that H2O2-induced apoptosis can be modulated by protective compounds, directly linking oxidative stress to intrinsic apoptosis in cardiac cells. Positive regulators of GO:1902177 are candidate targets for cardioprotection, whereas excessive inhibition could impair clearance of damaged cells.
Cancer therapy resistance
Many tumors evade apoptosis by downregulating positive regulators of the intrinsic pathway, including p53 and BH3-only proteins. Restoring or amplifying oxidative stress-induced intrinsic apoptosis is a therapeutic strategy, and GO:1902177 provides a functional framework for identifying sensitizers.
From positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for oxidative stress-induced apoptosis? | CRISPR knockout in H9c2 or neuronal cell lines followed by H2O2 challenge |
| Does a specific phosphorylation site regulate pro-apoptotic activity? | Point-mutation knock-in of phospho-dead or phospho-mimetic alleles |
| Does a disease-associated variant alter apoptotic sensitivity? | Knock-in of the variant into an isogenic cell line |
| Where does a protein localize during oxidative stress? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression sensitize cells to oxidative stress? | Doxycycline-inducible overexpression in cancer or neuronal cells |
| Does a gene modulate apoptosis in stem cells? | CRISPR knockout or overexpression in bone marrow mesenchymal stem cells |
How to Study the positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Caspase-3/7 activity assay | Executioner caspase activity | Quantifying apoptosis after H2O2 challenge |
| Annexin V flow cytometry | Phosphatidylserine externalization | Early apoptosis detection in cell models |
| JC-1 staining | Mitochondrial membrane potential | Assessing outer membrane permeabilization |
| Cytochrome c release assay | Cytosolic cytochrome c | Confirming intrinsic pathway engagement |
| TUNEL | DNA fragmentation | Late apoptosis quantification in tissues or cells |
| Mass spectrometry proteomics | Protein abundance and modifications | Mapping oxidative stress responses in disease models |
| RNA-seq | Transcript abundance | Identifying GO:1902177-associated gene expression changes |
| Live-cell imaging | ROS, mitochondrial dynamics, apoptosis timing | Dissecting positive regulation kinetics |
Apoptosis phenotyping assays
Caspase-3/7 activity, Annexin V flow cytometry, TUNEL, and mitochondrial membrane potential (JC-1) assays are standard for quantifying oxidative stress-induced intrinsic apoptosis. These readouts should be combined with H2O2 or rotenone challenge to specifically interrogate GO:1902177.
Proteomics and redox proteomics
Mass spectrometry-based proteomics can map changes in mitochondrial and stress-response proteins under oxidative stress, as demonstrated in retinal pericyte and epilepsy biomarker studies. Redox proteomics further identifies oxidized cysteines that may regulate positive regulators of apoptosis.
Transcriptomics and pathway analysis
RNA-seq followed by GO enrichment can identify genes annotated to GO:1902177 and related terms, helping prioritize candidates for functional testing. Integrating transcriptomic data with proteomic datasets strengthens causal inference.
Imaging and mitochondrial dynamics
Live-cell imaging of cytochrome c release, mitochondrial morphology, and ROS-sensitive dyes provides spatial and temporal resolution of positive regulation. Mitochondrial fission/fusion markers can be co-imaged to link dynamics to apoptosis.
How CRISPR Can Be Used to Study GO:1902177 positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway
Knockout
CRISPR knockout of candidate positive regulators such as BAX, CASP9, or MAPK8 allows direct testing of whether the gene is required for oxidative stress-induced intrinsic apoptosis. Isogenic knockout lines challenged with H2O2 provide clean causal evidence and can be used to validate GO:1902177 annotations.
Point Mutation
Point mutations can be introduced to test phosphorylation sites, catalytic residues, or disease-associated variants in positive regulators. For example, phospho-dead or phospho-mimetic alleles of BH3-only proteins can reveal how post-translational modifications tune apoptotic sensitivity.
Knock-in
Knock-in of epitope or fluorescent tags enables localization and interaction studies of positive regulators under oxidative stress. Disease-variant knock-in models can also reveal allele-specific effects on apoptosis thresholds.
Overexpression
Inducible overexpression of candidate positive regulators can sensitize cells to oxidative stress and confirm gain-of-function activity. This approach is useful for screening genes that amplify GO:1902177 in cancer or stem cell contexts.
How EDITGENE Supports positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway Research
Researchers studying positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway-related genes often need to determine whether a candidate gene is causally involved in amplifying mitochondrial apoptosis, rather than merely correlating with it. CRISPR-based models provide the gold-standard causal evidence, and EDITGENE offers a full suite of services to generate and characterize such models.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway research.
Frequently Asked Questions About positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway
What is GO:1902177?
GO:1902177 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of an oxidative stress-induced intrinsic apoptotic signaling pathway.
What genes are involved in positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway?
Key genes include BAX, BAK, BID, BIM, PUMA, TP53, APAF-1, CASP9, CASP3, CASP7, MAPK8, and MAPK14, based on experimental studies of oxidative stress-induced apoptosis.
How is oxidative stress-induced intrinsic apoptosis measured?
Common assays include caspase-3/7 activity, Annexin V flow cytometry, JC-1 mitochondrial potential, cytochrome c release, and TUNEL.
What is the difference between intrinsic and extrinsic apoptosis?
Intrinsic apoptosis is mitochondria-centered and triggered by internal stress such as ROS, whereas extrinsic apoptosis is initiated by death receptors; GO:1902177 specifically concerns the intrinsic pathway.
Which diseases involve positive regulation of oxidative stress-induced intrinsic apoptosis?
Neurodegeneration, temporal lobe epilepsy, diabetic retinopathy, ischemia-reperfusion injury, cardiomyopathy, and cancer therapy resistance have been linked to this process.
How can CRISPR help study GO:1902177?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of whether a gene positively regulates oxidative stress-induced apoptosis.
What is the role of p53 in oxidative stress-induced apoptosis?
TP53 transcriptionally induces pro-apoptotic BH3-only proteins and effectors such as PUMA and BAX, acting as a master positive regulator.
Can oxidative stress-induced apoptosis be inhibited for therapy?
Yes, protective compounds such as chlorogenic acid analogues have been shown to reduce H2O2-induced apoptosis in cardiomyoblasts, suggesting therapeutic potential.
What proteomic changes occur in oxidative stress-related disease?
Proteomic studies in diabetic retinal pericytes and epilepsy biomarker research reveal alterations in mitochondrial, antioxidant, and stress-response proteins.
How do I choose a model for studying positive regulators of oxidative stress-induced apoptosis?
Consider the biological context: H9c2 cardiomyoblasts for cardiac studies, neuronal lines for neurodegeneration, retinal pericyte-like cells for diabetic retinopathy, and mesenchymal stem cells for regenerative biology.
Conclusion
GO:1902177 provides a precise functional annotation for genes that amplify oxidative stress-induced intrinsic apoptosis, a process central to neurodegeneration, cardiovascular injury, diabetic complications, and cancer therapy resistance. By combining QuickGO-defined ontology with experimental evidence from cardiomyoblast, neuronal, and stem cell models, researchers can prioritize causal regulators and design mechanism-based interventions. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, together with proteomic and transcriptomic readouts, offer a rigorous path to dissect this pathway and translate findings into therapeutic strategies.
References
- 1. Rajendran S et al.. 2025. Proteome of pericytes from retinal vasculature of diabetic donor eyes.. Exp Eye Res 251:110178 PMID: 39580044
- 2. Timechko EE et al.. 2023. Mass Spectrometry as a Quantitative Proteomic Analysis Tool for the Search for Temporal Lobe Epilepsy Biomarkers: A Systematic Review.. Int J Mol Sci 24(13) PMID: 37446307
- 3. Yu BW et al.. 2016. Chlorogenic acid analogues from Gynura nepalensis protect H9c2 cardiomyoblasts against H(2)O(2)-induced apoptosis.. Acta Pharmacol Sin 37(11):1413-1422 PMID: 27593219
- 4. Dong XJ et al.. 2026. Exercise rejuvenates bone marrow mesenchymal stem cells associated with the inhibition of inflammatory factors and senescence-related factors.. Biochem Biophys Rep 46:102561 PMID: 42004533
